Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg
NCT01184391
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
DEPAKOTE® Tablets, 500 MG
DRUG:
DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP, 500 MG
Sponsor
Mylan Pharmaceuticals Inc